Pedro Ochoa Allemant, MD, MSCE
Gastroenterology
Headshot of Pedro Ochoa Allemant, MD, MSCE

Pedro Ochoa Allemant, MD, MSCE

Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
Headshot of Pedro Ochoa Allemant, MD, MSCE
Penn Medicine Provider

About me

  • Instructor A of Medicine (Gastroenterology)

My education and training

  • University of San Martin de PorresMedical School
  • Yale-New Haven HospitalResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English
Español
Spanish

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ochoa Allemant is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Ochoa-Allemant P, Kiran A, Mezzacappa C, Kaplan DE, Mahmud N. Steatotic Liver Disease has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the US Veterans Health System , Am J Gastroenterol, 121: 2026,1781-1784


Medina-Morales E, Shah Y, Xynogala A, Trivedi HD, Ochoa-Allemant P, Saberi B, Bonder A, Tafesh Z, Amin A, Lingiah V, Niazi M, Gaglio PJ, Paterno F, Lunsford KE. Redefining liver transplant priority: Waitlist outcomes for HCC after MMaT-3 donor hospital-based allocation reform , Liver Transpl: 2026


Mahmud N, Schechter MS, Zhang S, Mezzacappa C, Ochoa-Allemant P, Kaplan DE, Serper M. Intravenous albumin after outpatient paracentesis reduces the risk of AKI hospitalization: A national cohort study , Hepatology: 2026


Goebel AM, Sheng E, Ochoa-Allemant P, Reza N, Mahmud N. A Meta-Epidemiological Analysis of Sex Disparities in Hepatology Clinical Trials , Clin Gastroenterol Hepatol, 24(2): 2026,563-565


Ochoa-Allemant P, Hubbard RA, Kaplan DE, Serper M. Cause-specific mortality in patients with steatotic liver disease in the United States , J Hepatol, 83(4): 2025,860-869


Mezzacappa C, Ochoa-Allemant P, Serper M, Taddei TH, John BV, Kaplan DE, Mahmud N. Validation and Epidemiologic Definition of the Novel Steatotic Liver Disease Nomenclature in a National United States Cohort With Cirrhosis , Clin Gastroenterol Hepatol, 23(9): 2025,1588-1599.e7


Ochoa-Allemant P, Hubbard RA, Kaplan DE, Serper M. Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease , JAMA Intern Med, 185: 2025,986-995


Ochoa-Allemant P, Serper M, Wang RX, Tang H, Ghandour B, Khan S, Mahmud N. Waitlisting and liver transplantation for MetALD in the United States: An analysis of the UNOS national registry , Hepatology, 81: 2025,532-545


Ochoa-Allemant P, Marrero JA, Serper M. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States , Hepatol Commun, 7: 2023,e0324


Ochoa-Allemant P, Tate JP, Williams EC, Gordon KS, Marconi VC, Bensley KMK, Rentsch CT, Wang KH, Taddei TH, Justice AC; VA Family of EHR Cohorts (VACo Family). Enhanced Identification of Hispanic Ethnicity Using Clinical Data: A Study in the Largest Integrated United States Health Care System , Med Care, 61: 2023,200-205


View all publications